Eplerenone, a mineralocorticoid receptor inhibitor, reduces cirrhosis associated changes of hepatocyte glucose and lipid metabolism.

Autor: Mohib, Mohammad Mohabbulla1 (AUTHOR), Rabe, Sindy1 (AUTHOR), Nolze, Alexander1 (AUTHOR), Rooney, Michael2 (AUTHOR), Ain, Quratul2 (AUTHOR), Zipprich, Alexander2 (AUTHOR), Gekle, Michael1 (AUTHOR), Schreier, Barbara1,3 (AUTHOR) barbara.schreier@medizin.uni-halle.de
Zdroj: Cell Communication & Signaling. 12/20/2024, Vol. 22 Issue 1, p1-18. 18p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje